Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Biogen (NASDAQ: BIIB) Q3 2024 Earnings Call Oct 30, 2024, 8:30 a.m. ET ...

Here are some of the recent management changes that took place during the week: Biogen (NASDAQ:BIIB) said its Executive Vice ...

US Bancorp DE reduced its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 15.7% in the third quarter, according ...

Biogen's Q3 earnings report shows flat growth but highlights its value for risk-tolerant investors in CNS disease treatment.

Sage (SAGE) stock fell 18% post-market after the company released its Q3 earnings report and said it was ending development ...

Check the time stamp on this data. Updated AI-Generated Signals for Biogen Inc. (BIIB) available here: BIIB.

Biogen (BIIB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

Barclays analyst Carter Gould maintained a Hold rating on Biogen (BIIB – Research Report) today and set a price target of $180.00. The ...

On Monday, Biogen Inc (BIIB) stock saw a decline, ending the day at $184.65 which represents a decrease of $-5.51 or -2.90% from the prior close of $190.16. The stock opened at $190.16 and touched a ...

Truist Financial analyst Srikripa Devarakonda reiterated a Buy rating on Biogen (BIIB – Research Report) today and set a price target of ...

Ballentine Partners LLC lowered its stake in Biogen Inc. (NASDAQ:BIIB – Free Report) by 54.1% in the 3rd quarter, according ...